Reich, K., Silverberg, J. I., Papp, K. A.
, Deleuran, M., Katoh, N., Strober, B., Beck, L. A., de Bruin-Weller, M., Werfel, T., Zhang, F., Biswas, P., DiBonaventura, M. D., Chan, G., Johnson, S., Farooqui, S. A., Kerkmann, U. & Clibborn, C. (2023).
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.
Journal of the European Academy of Dermatology and Venereology : JEADV,
37(10), 2056-2066.
https://doi.org/10.1111/jdv.19280Balieva, F. N., Catton, L., Claréus, B. W., Danielsen, K., Fierens, F.
, Iversen, L., Koulu, L., Osmanecevic, A., Pasternack, R. & Skov, L. (2023).
Treatment Preferences in Young Adults with Moderate to Severe Psoriasis: A Qualitative Study from the Nordic Countries.
Dermatology and Therapy,
13(8), 1873-1887.
https://doi.org/10.1007/s13555-023-00973-5Dale, H., Fenstad, A. M., Hallan, G., Overgaard, S.
, Pedersen, A. B., Hailer, N. P., Kärrholm, J., Rolfson, O., Eskelinen, A., Mäkelä, K. T. & Furnes, O. (2023).
Increasing risk of revision due to infection after primary total hip arthroplasty: results from the Nordic Arthroplasty Register Association.
Acta Orthopaedica,
94, 307-315.
https://doi.org/10.2340/17453674.2023.13648